Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Paget's Disease of Bone: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Paget's Disease of Bone: 1 US clinical trial tracked, none currently recruiting.

Paget's Disease of Bone is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Novartis Pharmaceuticals, running 1 of these trials.

Enrollment posture brief

Registry condition pagets-disease-of-bone

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Paget's Disease of Bone (thi…0%
Open-enrollment share among volume-matched conditions near Paget's Disease of Bone

Paget's Disease of Bone has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Paget's Disease of Bone on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Paget's Disease of Bone is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Paget's Disease of Bone records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Calcium and vitamin D supplements Drug
1 trials
Placebo to risedronate Drug
1 trials
placebo to zoledronic acid Drug
1 trials
zoledronic acid Drug
1 trials
Risedronate Drug
1 trials

US sites by state

Facility locations filed on Paget's Disease of Bone trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
South Carolina 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
Massachusetts 1 trials
Louisiana 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Paget's Disease of Bone page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Paget's Disease of Bone trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Novartis Pharmaceuticals sponsors the most Paget's Disease of Bone trials on record, review their full trial history before evaluating a specific study. See Novartis Pharmaceuticals's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Paget's Disease of Bone condition card totals 1 registered trials; most-linked intervention Calcium and vitamin D supplements; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.